(Q46715544)

English

Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography

scientific article published in May 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16177807

Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16177807

author name string

Bart N M van Berckel

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16177807

Lawrence S Kegeles

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16177807

Rikki Waterhouse

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16177807

Ningning Guo

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16177807

Dah-Ren Hwang

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16177807

Yiyun Huang

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16177807

Rajesh Narendran

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16177807

Ronald Van Heertum

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16177807

Marc Laruelle

9

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16177807

language of work or name

0 references

publication date

1 May 2006

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16177807

Neuropsychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16177807

31

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16177807

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16177807

967-977

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16177807

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300902

0 references

Ketamine does not decrease striatal dopamine D2 receptor binding in man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Neurotransmitter interactions in schizophrenia--therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Dopamine in schizophrenia: a review and reconceptualization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Pharmacokinetics in Intravenous Anaesthetic Practice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Metabotropic glutamate receptor agonists inhibit endogenous glutamate release from rat striatal synaptosomes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Evaluation of ultrafiltration for the free-fraction determination of single photon emission computed tomography (SPECT) radiotracers: beta-CIT, IBF, and iomazenil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

PET study of the [11C]raclopride binding in the striatum of the awake cat: effects of anaesthetics and role of cerebral blood flow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Distinct inhibition of acute cocaine-stimulated motor activity following microinjection of a group III metabotropic glutamate receptor agonist into the dorsal striatum of rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxioly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Molecular diversity and functions of glutamate receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Glutamate receptor dysfunction and schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Endogenous dopamine release after pharmacological challenges in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

New perspectives for the development of selective metabotropic glutamate receptor ligands.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Pharmacological agents acting at subtypes of metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Dopamine receptors and the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Effects of lesions in the medial prefrontal cortex on the activity of midbrain dopamine neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Target-specific glutamatergic regulation of dopamine neurons in the ventral tegmental area

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Abnormal excitatory neurotransmitter metabolism in schizophrenic brains

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Comparative effects of methamphetamine and nicotine on the striatal [(11)C]raclopride binding in unanesthetized monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Implications of normal brain development for the pathogenesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

N-acetylaspartylglutamate activates cyclic AMP-coupled metabotropic glutamate receptors in cerebellar astrocytes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

21 January 2018

Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

7 January 2021

based on heuristic

inferred from DOI database lookup

Interaction between A1 adenosine and class II metabotropic glutamate receptors in the regulation of purine and glutamate release from rat hippocampal slices

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

7 January 2021

based on heuristic

inferred from DOI database lookup

Burst firing induced in midbrain dopamine neurons by stimulation of the medial prefrontal and anterior cingulate cortices

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

7 January 2021

based on heuristic

inferred from DOI database lookup

A simple synthesis of [11C]methyl triflate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

7 January 2021

based on heuristic

inferred from DOI database lookup

The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: an effect mediated by ventral tegmental area.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

7 January 2021

based on heuristic

inferred from DOI database lookup

A method for the solution of certain non-linear problems in least squares

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of group III metabotropic glutamate receptors inhibits basal and amphetamine-stimulated dopamine release in rat dorsal striatum: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of amphetamine, methamphetamine and desmethyldeprenyl in human plasma by gas chromatography/negative ion chemical ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabotropic glutamate receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholinergic neuronal modulation alters dopamine D2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: positron emission tomography studies with microdialysis in the conscious monkey brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

7 January 2021

based on heuristic

inferred from DOI database lookup

Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of [11C]raclopride?: PET studies combined with microdialysis in conscious monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid Automated Algorithm for Aligning and Reslicing PET Images

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

7 January 2021

based on heuristic

inferred from DOI database lookup

N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300902

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1300902

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16177807

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16177807

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46715544&oldid=2127988940"